| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |